Why is Nath Bio-Genes falling/rising?

As of 10-Jul, Nath Bio-Genes (India) Ltd is experiencing a decline in its stock price, currently at Rs 224.00, which represents a decrease of Rs 11.65 or 4.94%. Today's price summary indicates that the stock has underperformed its sector by 4.16% and has fallen after five consecutive days of gains, reaching an intraday low of Rs 224. The stock is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting some underlying strength. However, the stock has generated a negative return of -10.08% over the past year, with profits declining by 8%. The company has also reported negative results for the last three consecutive quarters, contributing to concerns about its long-term fundamental strength.
In the broader market context, the stock has shown a short-term return of +6.79% over the past week, while the Sensex has remained nearly flat with a change of -0.06%. Despite this short-term outperformance, the stock has consistently underperformed against the benchmark over the last three years, with a significant decline of -31.71% over the past five years compared to the Sensex's +127.33%. The weak long-term growth indicators, such as a low Return on Capital Employed (ROCE) and declining profits, further exacerbate the stock's challenges, leading to a cautious outlook among investors.